Vinay Prasad, the top vaccine regulator and chief scientific officer at the Food and Drug Administration (FDA) and a critic of the agency’s COVID-19 policies, has departed after being on the job ...

Prasad’s short FDA tenure brought stricter review standards for gene and COVID vaccines, sparking biotech concern and political backlash.

The motivation is solely what we think is in the public interest— the accurate judgment of benefits and risks,” Prasad wrote.

Other changes under Prasad, who was also the agency's chief medical and science officer, included a new policy limiting the ...

The new documents offer a window into Dr. Prasad’s vision for the agency and his thinking on vaccine policy. The records reveal that F.D.A. staff members concluded that the vaccines were safe ...

Prasad's exit ends a tumultuous tenure during which he led a reworking of agency guidelines on COVID vaccines and his office ...

Makary and Prasad co-authored a paper in 2022 in the British Medical Journal, finding that COVID-19 booster mandates for teenagers and young adults did more harm than good, particularly causing ...

Dr. Vinay Prasad had been serving as the FDA's director of the Center for Biologics Evaluation and Research since May, and ...

Vinay Prasad, MD, MPH, a frequent critic of the FDA and COVID-19 lockdowns and vaccination policies, will be the next director of FDA's Center for Biologics Evaluation and Research (CBER), the ...

The Food and Drug Administration (FDA) has tapped Vinay Prasad, a prominent critic of federal COVID-19 policies and a proponent of more stringent approval standards, to lead the agency’s ...

Annual COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift unveiled Tuesday by the Trump administration.